Cargando…

Efficacy of Repeated Courses of Rituximab as Treatment for Pemphigus Vulgaris

Rituximab targets the B-lymphocyte antigen CD20, providing pemphigus vulgaris patients with long-term remissions. However, the effects of repeated courses have not yet been established. This study aimed to evaluate the effect of repeated rituximab courses on remission length in pemphigus vulgaris. A...

Descripción completa

Detalles Bibliográficos
Autores principales:	BAUM, Sharon, RAVIV, Tal, GILBOA, Sarit, PAVLOTSKY, Felix, BARZILAI, Aviv
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society for Publication of Acta Dermato-Venereologica 2020
Materias:	Clinical Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274918/ https://www.ncbi.nlm.nih.gov/pubmed/32985675 http://dx.doi.org/10.2340/00015555-3649

Ejemplares similares

Illness Perception, Perceived Social Support and Quality of Life in Patients with Pemphigus Vulgaris: What Should Dermatologists Know?
por: SEGAL, Oz, et al.
Publicado: (2021)

Relationship Between Pemphigus Vulgaris Severity and PCR-positive Herpes Simplex Virus
por: BAUM, Sharon, et al.
Publicado: (2022)

Rituximab in the Treatment of Pemphigus Vulgaris
por: Zakka, Labib R., et al.
Publicado: (2012)

Rituximab: Aggressive course of pemphigus vulgaris: case report
Publicado: (2021)

Successful Treatment of Recalcitrant Pediatric Pemphigus Vulgaris With Rituximab
por: Santiago-Vázquez, Marely, et al.
Publicado: (2022)

Rituximab therapy improves recalcitrant Pemphigus vulgaris
por: Noormohammadpour, Pedram, et al.
Publicado: (2015)

Cerebral toxoplasmosis after rituximab for pemphigus vulgaris
por: Lee, Erica B., et al.
Publicado: (2019)

AZD-1222/rituximab: Pemphigus vulgaris and pemphigus vulgaris flare-up: 2 case reports
Publicado: (2022)

Role of Rituximab in the Treatment of Pemphigus Vulgaris: Patient Selection and Acceptability
por: Ciolfi, Christian, et al.
Publicado: (2022)

Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil
por: Biot, Stephanie Del Rio Navarrete, et al.
Publicado: (2014)

Identification of a Functional Risk Variant for Pemphigus Vulgaris in the ST18 Gene
por: Vodo, Dan, et al.
Publicado: (2016)

The efficacy of acyclovir in treatment of the pemphigus vulgaris
por: Iraji, Fariba, et al.
Publicado: (2013)

Pemphigus vulgaris successfully treated with ocrelizumab following rituximab allergy
por: Benesh, Gabrielle, et al.
Publicado: (2021)

Thrombotic Storm Induced by Rituximab in a Patient With Pemphigus Vulgaris
por: Karan, Abhinav, et al.
Publicado: (2023)

Crusted scabies in a patient with pemphigus vulgaris after treatment with rituximab and corticosteroids
por: Ashrafzadeh, Sepideh, et al.
Publicado: (2020)

Immunocytometric Analysis of Oral Pemphigus vulgaris Patients after Treatment with Rituximab as Adjuvant
por: Fortuna, Giulio, et al.
Publicado: (2021)

Alopecia areata after denosumab treatment for osteoporosis
por: Lyakhovitsky, Anna, et al.
Publicado: (2016)

Brain Abscess following Rituximab Infusion in a Patient with Pemphigus Vulgaris
por: Al-Harbi, Talal M., et al.
Publicado: (2015)

Rituximab in Pemphigus Vulgaris: A Review of Monoclonal Antibody Therapy in Dermatology
por: Khandelwal, Krishna, et al.
Publicado: (2023)

Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid‐sparing effect
por: Chen, D.M., et al.
Publicado: (2019)

Comparison of rituximab and conventional adjuvant therapy for pemphigus vulgaris: A retrospective analysis
por: Agarwal, Ashwin, et al.
Publicado: (2018)

T Cells Remember SARS-CoV-2 in Rituximab-Treated Pemphigus Vulgaris
por: Croitoru, David O., et al.
Publicado: (2023)

Pemphigus vulgaris
por: Tamgadge, Sandhya, et al.
Publicado: (2011)

Pemphigus vulgaris
por: Porro, Adriana Maria, et al.
Publicado: (2019)

The Evaluation of Thyroid Diseases in Patients with Pemphigus Vulgaris
por: Kavala, Mukaddes, et al.
Publicado: (2012)

Illness perception, coping, and quality of life in early-stage Mycosis fungoides()()
por: Segal, Oz, et al.
Publicado: (2021)

A Comparative Study to Evaluate the Efficacy and Cost of Rituximab versus Dexamethasone Cyclophosphamide Pulse in Patients of Pemphigus Vulgaris
por: Das, Sudip, et al.
Publicado: (2021)

Severe Multi-Resistant Pemphigus vulgaris: prolonged remission with a single cycle of Rituximab
por: Corral, Isabela Soubhia, et al.
Publicado: (2013)

Hepatitis B reactivation in patients with pemphigus vulgaris after immunosuppressive therapy including rituximab
por: Yoo, Dae San, et al.
Publicado: (2020)

Pemphigus vulgaris with refractory gingival ulcerations, successfully treated with rituximab—A case report
por: Dolenc‐Voljč, Mateja, et al.
Publicado: (2022)

Childhood pemphigus vulgaris is a challenging diagnosis
por: Lins, Gastão Tenório, et al.
Publicado: (2021)

Radiation-Associated Pemphigus Vulgaris in a Patient With Preceding Malignancy: Treatment With Rituximab as a Valuable Option
por: Schauer, Franziska, et al.
Publicado: (2020)

Biosimilars in Pemphigus Vulgaris
por: Patil, Sharmila, et al.
Publicado: (2014)

Management of Pemphigus Vulgaris
por: Cholera, Mimansa, et al.
Publicado: (2016)

The Genetics of Pemphigus Vulgaris
por: Vodo, Dan, et al.
Publicado: (2018)

Oral Pemphigus Vulgaris
por: Subadra, K, et al.
Publicado: (2021)

Successful treatment with thalidomide for pemphigus vulgaris
por: Zhang, Bingjie, et al.
Publicado: (2020)

Rituximab therapy in a case of pemphigus vulgaris triggering herpes simplex infection at varied sites
por: Chotaliya, Kiran K., et al.
Publicado: (2015)

Serum sickness following rituximab therapy in a patient with pemphigus vulgaris: A case report
por: Khatib, Mohamad Y., et al.
Publicado: (2020)

SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris
por: Fenizia, Claudio, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hecejau31nsd9ppn2qfnn8627r